Cargando…
Correction: Potent and specific MTH1 inhibitors targeting gastric cancer
Autores principales: | Zhou, Wenjuan, Ma, Liying, Yang, Jing, Qiao, Hui, Li, Lingyu, Guo, Qian, Ma, Jinlian, Zhao, Lijuan, Wang, Junwei, Jiang, Guozhong, Wan, Xiangbin, Goscinski, Mariusz Adam, Ding, Lina, Zheng, Yichao, Li, Wencai, Liu, Hongmin, Suo, Zhenhe, Zhao, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567784/ https://www.ncbi.nlm.nih.gov/pubmed/33067425 http://dx.doi.org/10.1038/s41419-020-03010-x |
Ejemplares similares
-
Potent and specific MTH1 inhibitors targeting gastric cancer
por: Zhou, Wenjuan, et al.
Publicado: (2019) -
Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A)
por: Li, Zhonghua, et al.
Publicado: (2019) -
Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer
por: Zhao, Jing, et al.
Publicado: (2020) -
High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer
por: Zhang, Meng, et al.
Publicado: (2018) -
Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2
por: Carter, Megan, et al.
Publicado: (2015)